2020. Early Changes in Patient-Relevant Endpoints in Three Tralokinumab Pivotal Phase 3 Trials (ECZTRA 1−3) in Adult Patients with Moderate-to-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine. 4, 6 (Oct. 2020), s98. DOI:https://doi.org/10.25251/skin.4.supp.98.